[Pharmacology. The proper use of drugs. 10/12. The preparation and administration of antineoplastic agents and adjuvants]. 2000

M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
Pharmacie Centrale, CHU de Besançon.

UI MeSH Term Description Entries
D009859 Oncology Nursing A nursing specialty concerned with the care provided to cancer patients. It includes aspects of family functioning through education of both patient and family. Nursing, Oncologic,Oncologic Nursing,Cancer Nursing,Oncological Nursing,Nursing, Cancer,Nursing, Oncological,Nursing, Oncology
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016903 Drug Monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug

Related Publications

M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
September 1976, The Medical clinics of North America,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
February 1986, Nihon rinsho. Japanese journal of clinical medicine,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
January 1979, Journal of the Tennessee Medical Association,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
June 1981, Mayo Clinic proceedings,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
January 1999, Soins; la revue de reference infirmiere,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
July 1978, Drugs,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
August 1984, Bollettino chimico farmaceutico,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
June 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
April 1983, The Medical journal of Australia,
M B Valnet-Rabier, and S Limat, and M C Woronoff-Lemsi, and J P Belon
June 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!